Jeff Cohen
Stock Analyst at Ladenburg Thalmann
(2.54)
# 2,127
Out of 4,829 analysts
12
Total ratings
60%
Success rate
11.76%
Average return
Main Sectors:
Stocks Rated by Jeff Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NMTC NeuroOne Medical Technologies | Initiates: Buy | $1.45 | $0.62 | +135.70% | 1 | May 5, 2025 | |
| CBLL CeriBell | Initiates: Buy | $32 | $15.97 | +100.38% | 1 | Apr 4, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $31 | $13.95 | +122.22% | 1 | Feb 20, 2025 | |
| LGCY Legacy Education | Maintains: Buy | $9.1 → $11 | $7.19 | +50.21% | 2 | Feb 14, 2025 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $3.84 | - | 1 | Nov 15, 2024 | |
| SNOA Sonoma Pharmaceuticals | Initiates: Buy | $65 | $3.15 | +1,963.49% | 1 | Sep 5, 2023 | |
| DKNG DraftKings | Initiates: Overweight | $52 | $36.23 | +43.53% | 1 | Jul 1, 2020 | |
| SE Sea Limited | Initiates: Overweight | $130 | $139.17 | -6.59% | 1 | Jul 1, 2020 | |
| TTWO Take-Two Interactive Software | Maintains: Equal-Weight | $110 → $130 | $226.55 | -42.62% | 3 | May 21, 2020 |
NeuroOne Medical Technologies
May 5, 2025
Initiates: Buy
Price Target: $1.45
Current: $0.62
Upside: +135.70%
CeriBell
Apr 4, 2025
Initiates: Buy
Price Target: $32
Current: $15.97
Upside: +100.38%
Beta Bionics
Feb 20, 2025
Initiates: Buy
Price Target: $31
Current: $13.95
Upside: +122.22%
Legacy Education
Feb 14, 2025
Maintains: Buy
Price Target: $9.1 → $11
Current: $7.19
Upside: +50.21%
Bionano Genomics
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.84
Upside: -
Sonoma Pharmaceuticals
Sep 5, 2023
Initiates: Buy
Price Target: $65
Current: $3.15
Upside: +1,963.49%
DraftKings
Jul 1, 2020
Initiates: Overweight
Price Target: $52
Current: $36.23
Upside: +43.53%
Sea Limited
Jul 1, 2020
Initiates: Overweight
Price Target: $130
Current: $139.17
Upside: -6.59%
Take-Two Interactive Software
May 21, 2020
Maintains: Equal-Weight
Price Target: $110 → $130
Current: $226.55
Upside: -42.62%